← Evidence map

ArticleScientific reports2024

EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer.

Jianyuan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39730634